Eton Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights

Eton Pharmaceuticals Inc share price today is $22.55, up 7.46%. The stock opened at $21.61 against the previous close of $20.77, with an intraday high of $22.92 and low of $20.5.

Eton Pharmaceuticals Inc Share Price Chart

Eton Pharmaceuticals Inc

us-stock
To Invest in {{usstockname}}
us-stock

Eton Pharmaceuticals Inc Share Price Performance

$22.55 0.0746(7.46%) ETON at 23 Mar 2026 12:56 PM Drug Manufacturers - Specialty & Generic
Lowest Today 20.5
Highest Today 22.92
Today’s Open 21.61
Prev. Close 20.77
52 Week High 23.00
52 Week Low 11.09
Day’s Range: Low 20.5 High 22.92
52-Week Range: Low 11.09 High 23.00
1 day return -
1 Week return +17.7
1 month return +21.88
3 month return +34.52
6 month return +21.55
1 year return +50.6
3 year return +454.85
5 year return +191.56
10 year return -

Eton Pharmaceuticals Inc Institutional Holdings

Opaleye Management Inc 10.66

EcoR1 Capital, LLC 7.57

BlackRock Inc 6.36

Vanguard Group Inc 5.03

Nantahala Capital Management, LLC 4.39

Vanguard Total Stock Mkt Idx Inv 2.67

JPMorgan Chase & Co 2.62

iShares Russell 2000 ETF 2.31

Morgan Stanley - Brokerage Accounts 2.19

Geode Capital Management, LLC 2.11

Royal Bank of Canada 1.79

Westside Investment Management, Inc. 1.76

State Street Corp 1.63

Oberweis Asset Management Inc 1.61

Oberweis Micro-Cap 1.57

Oberweis Micro-Cap Growth 1.57

Thompson, Siegel & Walmsley LLC 1.52

Divisadero Street Capital Management, LP 1.11

BNP Paribas Arbitrage, SA 1.03

Vanguard Institutional Extnd Mkt Idx Tr 0.94

Fidelity Small Cap Index 0.93

Northern Trust Corp 0.91

UBS Group AG 0.82

Cannell Capital LLC 0.81

iShares Russell 2000 Growth ETF 0.81

Renaissance Technologies Corp 0.77

Soleus Capital Management, L.P. 0.75

Fidelity Extended Market Index 0.46

Vanguard Russell 2000 ETF 0.46

State St Russell Sm/Mid Cp® Indx SL Cl I 0.45

State St Russell Sm Cap® Indx SL Cl I 0.34

Bridgeway Ultra-Small Company 0.27

iShares Micro-Cap ETF 0.25

Schwab Small Cap Index 0.24

Timpani Small Cap Growth Equity 0.21

NT R2000 Index Fund - NL 0.21

Blackrock Extended Mkt Fund CF 0.20

iShares Core S&P Total US Stock Mkt ETF 0.19

Extended Equity Market Fund K 0.17

NT R2000 Index Fund - DC - NL - 3 0.17

Eton Pharmaceuticals Inc Market Status

Strong Buy: 2

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Eton Pharmaceuticals Inc Fundamentals

Market Cap 598.57 M

PB Ratio 25.8365

PE Ratio 0.0

Enterprise Value 591.22 M

Total Assets 92.11 M

Volume 896998

Eton Pharmaceuticals Inc Company Financials

Annual Revenue FY23:32827000 32.8M, FY22:21251000 21.3M, FY21:21832000 21.8M, FY20:39000 0.0M, FY19:959000 1.0M

Annual Profit FY23:23791000 23.8M, FY22:14318000 14.3M, FY21:19209000 19.2M, FY20:-247000 -0.2M, FY19:506000 0.5M

Annual Net worth FY23:2232000 2.2M, FY22:-9782000 -9.8M, FY21:-2961000 -3.0M, FY20:-28829000 -28.8M, FY19:-18039000 -18.0M

Quarterly Revenue Q3/2025:22459000 22.5M, Q2/2025:18928000 18.9M, Q1/2025:17282000 17.3M, Q3/2024:10324000 10.3M, Q2/2024:9074000 9.1M

Quarterly Profit Q3/2025:7855000 7.9M, Q2/2025:11924000 11.9M, Q1/2025:9861000 9.9M, Q3/2024:6302000 6.3M, Q2/2024:5626000 5.6M

Quarterly Net worth Q3/2025:-1927000 -1.9M, Q2/2025:-2585000 -2.6M, Q1/2025:-1572000 -1.6M, Q3/2024:627000 0.6M, Q2/2024:-3041000 -3.0M

About Eton Pharmaceuticals Inc & investment objective

Company Information Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-400 for treating adrenal insufficiency; ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Organisation Drug Manufacturers - Specialty & Generic

Employees 44

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Sean E. Brynjelsen

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Eton Pharmaceuticals Inc FAQs

What is the share price of Eton Pharmaceuticals Inc today?

The current share price of Eton Pharmaceuticals Inc is $22.55.

Can I buy Eton Pharmaceuticals Inc shares in India?

Yes, Indian investors can buy Eton Pharmaceuticals Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Eton Pharmaceuticals Inc shares in India?

You can easily invest in Eton Pharmaceuticals Inc shares from India by:

Can I buy fractional shares of Eton Pharmaceuticals Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Eton Pharmaceuticals Inc?

Eton Pharmaceuticals Inc has a market cap of $598.57 M.

In which sector does Eton Pharmaceuticals Inc belong?

Eton Pharmaceuticals Inc operates in the Drug Manufacturers - Specialty & Generic sector.

What documents are required to invest in Eton Pharmaceuticals Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Eton Pharmaceuticals Inc?

The PE ratio of Eton Pharmaceuticals Inc is N/A and the PB ratio is 25.84.